{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:31:49Z","timestamp":1795087909826,"version":"4.10.2"},"reference-count":30,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2013,4,14]]},"published-print":{"date-parts":[[2014,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      No trial has compared non-bismuth quadruple \u2018sequential\u2019 and \u2018concomitant\u2019 regimens in settings with increasing clarithromycin rates. The study aims to compare the effectiveness and safety of these therapies for\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      Prospective randomised clinical trial in 11 Spanish hospitals. Patients na\u00efve to eradication therapy with non-investigated\/functional dyspepsia or peptic ulcer disease were included. Randomised (1:1) to sequential (omeprazole (20\u2005mg\/12\u2005h) and amoxicillin (1\u2005g\/12\u2005h) for 5\u2005days, followed by 5\u2005days of omeprazole (20\u2005mg\/12\u2005h), clarithromycin (500\u2005mg\/12\u2005h) and metronidazole (500\u2005mg\/12\u2005h)), or concomitant treatment (same drugs taken concomitantly for 10\u2005days). Eradication was confirmed with\n                      <jats:sup>13<\/jats:sup>\n                      C-urea breath test or histology 4\u2005weeks after treatment. Adverse events (AEs) and compliance were evaluated with questionnaires and residual medication count.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>338 consecutive patients were randomised. Mean age was 47\u2005years, 60% were women, 22% smokers and 20% had peptic ulcer. Concomitant and sequential eradication rates were, respectively, 87% vs 81% by intention-to-treat (p=0.15) and 91% vs 86% (p=0.131) per protocol. Respective compliances were 83% vs 82%. Treatment-emergent AEs were reported in 59% of patients (no differences found between treatments). AEs were mostly mild (60%), and average length was 6.1\u2005days, causing discontinuation only in 12 patients. Multivariate analysis: \u2018concomitant\u2019 treatment showed an OR of 1.5 towards better eradication rate in a borderline significance CI (95% CI 0.9 to 2.8).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Concomitant therapy led to a non-statistically significant advantage (5%) over sequential therapy, coming closer to 90% cure rates. Both therapies showed an acceptable safety profile.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>ClincialTrials.gov:<\/jats:bold>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT01273441\">NCT01273441<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2013-304820","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T20:10:33Z","timestamp":1368303033000},"page":"244-249","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":110,"title":["Randomised clinical trial comparing sequential and concomitant therapies for\n                    <i>Helicobacter pylori<\/i>\n                    eradication in routine clinical practice"],"prefix":"10.1136","volume":"63","clinical-trial-number":[{"clinical-trial-number":"nct01273441","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Adrian G","family":"McNicholl","sequence":"first","affiliation":[{"name":"Digestive Services, Hospital Universitario de La Princesa and Instituto de Investigaci\u00f3n Sanitaria Princesa (IP), Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain\u00a0"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia C","family":"Marin","sequence":"additional","affiliation":[{"name":"Digestive Services, Hospital Universitario de La Princesa and Instituto de Investigaci\u00f3n Sanitaria Princesa (IP), Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain\u00a0"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Molina-Infante","sequence":"additional","affiliation":[{"name":"Digestive Services, Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, C\u00e1ceres, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Castro","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain\u00a0"},{"name":"Digestive Services, Hospital Ntra. Sra. Virgen de Valme, Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Barrio","sequence":"additional","affiliation":[{"name":"Digestive Services, Hospital Universitario R\u00edo Hortega, Valladolid, Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Ducons","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain\u00a0"},{"name":"Digestive Services, Hospital Cl\u00ednico Universitario \u2018Lozano Blesa\u2019, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Calvet","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain\u00a0"},{"name":"Digestive Services, Hospital de Sabadell, Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristobal","family":"de la Coba","sequence":"additional","affiliation":[{"name":"Digestive Services, Hospital de Cabue\u00f1es, Gij\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Montoro","sequence":"additional","affiliation":[{"name":"Digestive Services, Hospital de San Jorge, Huesca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Bory","sequence":"additional","affiliation":[{"name":"Digestive Services, Hospital del Mar, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles","family":"Perez-Aisa","sequence":"additional","affiliation":[{"name":"Digestive Unit, Agencia Sanitaria Costa del Sol, Marbella, M\u00e1laga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Forn\u00e9","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain\u00a0"},{"name":"Digestive Services, Hospital Mutua de Terrassa, Terrassa, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier P","family":"Gisbert","sequence":"additional","affiliation":[{"name":"Digestive Services, Hospital Universitario de La Princesa and Instituto de Investigaci\u00f3n Sanitaria Princesa (IP), Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain\u00a0"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the participant centres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,5,11]]},"reference":[{"key":"2025121219393384000_63.2.244.1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31820fb8f6"},{"key":"2025121219393384000_63.2.244.2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302084"},{"key":"2025121219393384000_63.2.244.3","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.132"},{"key":"2025121219393384000_63.2.244.4","first-page":"177","article-title":"Infection with Helicobacter pylori","volume":"61","author":"IARC","year":"1994","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"2025121219393384000_63.2.244.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01393.x"},{"key":"2025121219393384000_63.2.244.6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4321\/S1130-01082005000500007","article-title":"Indications, diagnostic tests and Helicobacter pylori eradication therapy. Recommendations by the 2nd Spanish Consensus Conference","volume":"97","author":"Mones","year":"2005","journal-title":"Rev Esp Enferm Dig"},{"key":"2025121219393384000_63.2.244.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2980.2008.00342.x"},{"key":"2025121219393384000_63.2.244.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01819.x"},{"key":"2025121219393384000_63.2.244.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05982.x"},{"key":"2025121219393384000_63.2.244.10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302254"},{"key":"2025121219393384000_63.2.244.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04887.x"},{"key":"2025121219393384000_63.2.244.12","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.192757"},{"key":"2025121219393384000_63.2.244.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.07.002"},{"key":"2025121219393384000_63.2.244.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05191.x"},{"key":"2025121219393384000_63.2.244.15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01461.x"},{"key":"2025121219393384000_63.2.244.16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MCG.0b013e3181c8a1a3","article-title":"Sequential therapy for Helicobacter pylori eradication: a critical review","volume":"44","author":"Gisbert","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"2025121219393384000_63.2.244.17","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181d7a16c"},{"key":"2025121219393384000_63.2.244.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2980.2012.00575.x"},{"key":"2025121219393384000_63.2.244.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.09.030"},{"key":"2025121219393384000_63.2.244.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60825-8"},{"key":"2025121219393384000_63.2.244.21","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(82)90024-1"},{"key":"2025121219393384000_63.2.244.22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01566.x"},{"key":"2025121219393384000_63.2.244.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2007.05.016"},{"key":"2025121219393384000_63.2.244.24","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31820ac05e"},{"key":"2025121219393384000_63.2.244.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2011.00826.x"},{"key":"2025121219393384000_63.2.244.26","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S25419"},{"key":"2025121219393384000_63.2.244.27","doi-asserted-by":"crossref","unstructured":"Gisbert JP Calvet X Bermejo F . III Spanish Consensus Conference on Helicobacter pylori infection. Gastroenterol Hepatol Published Online First: 17 April 2013. doi: 10.1016\/j.gastrohep.2013.01.011","DOI":"10.1016\/j.gastrohep.2013.01.011"},{"key":"2025121219393384000_63.2.244.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05211.x"},{"key":"2025121219393384000_63.2.244.29","first-page":"725 e1","article-title":"Clinical practice guideline on the management of patients with dyspepsia. Update 2012","volume":"35","author":"Gisbert","year":"2012","journal-title":"Gastroenterol Hepatol"},{"key":"2025121219393384000_63.2.244.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2012.00947.x"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2013-304820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T03:39:43Z","timestamp":1765597183000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2013-304820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,11]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,12,30]]},"published-print":{"date-parts":[[2014,2]]}},"alternative-id":["10.1136\/gutjnl-2013-304820"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2013-304820","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718009662.793478841","asserted-by":"object"}]},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,11]]}}}